The question we are probably all asking ourselves these days is: what will happen to our companies, associations or institutions in the coming weeks and months? Unfortunately, we cannot answer this question either, but we would like to be available for you after and during the ‘lockdown’ and have expanded our analytics for your tests as part of your corona virus distribution prevention.
What is the advantage of corporate corona prevention screening? Our analytics are used, for example, when examining your healthy employees or when examining surfaces. In this way, the spread in the company by employees with asymptomatic corona infection or in early stages of infection with high viral load can be contained and plant closures avoided.
How long does our analysis take? We can provide a test result in 24-48 hours or as part of our express testing on the same working day.
What do you have to consider with a positive result? A positive tested employee should be quarantined immediately and introduced to a doctor to ensure the result. Employees who have been in contact should be informed and, depending on the risk assessment (e.g. contact time), possibly send to quarantine. Further recommendations for tracking infection according to risk can be found on the website of the RKI.
Further information about the service can be found in the Virus Analysis tab. Please contact us if you are interested in capacities, prices and requirements e.g. sampling conditions.
Informationen about the virus:
“The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) is one of the largest single-stranded RNA viruses known to date and belongs to the Coronaviridae family. It belongs to the genus Betacoronavirus and has a diameter of approximately 125 nm. The SARS-CoV Virion is characterized by a relatively high stability against environmental factors and detergents. It has been determined that the virus can still be infectious on surfaces after 72-96 hours. The latest variant, the so-called SARS-CoV-2, was first described in 2020 and currently has WHO pandemic status. ” – Dr. Adrian Mehlitz, Head of Service
